Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
Purpose: The C-TRIUMPH study has identified 20 household contacts (HHC), who have progressed to active TB from its HHCs cohort...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
